Hospira, Inc.

275 North Field Drive,
Lake Forest, Illinois 60045
United States,
(224) 212-2000
www.hospira.com

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. Hospira, Inc. is based in Lake Forest, Illinois.

M&A Summary

Buy vs Sell

Year ≤ '13 '14 '15 '16 '17 '18 T
Buy (0.0/yr) # 8 - - - - - 8
vol $2.6B $2.6B
Sell (0.2/yr) # 2 1 - - - - 3
vol $117M $117M
  11

Top M&A Advisors

Financial Deals
Sign-up to View
1
Legal Deals
Sign-up to View
1
Sign-up to View
1

Deal Values

Buy # TOTAL
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest Mayne Pharma Ltd.
$2.0B (2006-10-20)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View
Largest TheraDoc, Inc.
$117M (2014-08-05)

Hospira was acquired by Pfizer on February 05, 2015.

Hospira has acquired 8 companies of its own. It has also divested 3 assets.

Hospira’s largest acquisition to date was in 2006, when it acquired Mayne Pharma for $2.0B. It’s largest disclosed sale occurred in 2014, when it sold TheraDoc to Premier for $117M. Hospira has acquired in 4 different US states, and 3 countries. The Company’s most targeted sectors include healthcare services (38%) and life science (25%).

When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 409 life science companies that have made at least 1 acquisition, 15 have acquired at least 5 companies, and 2 have acquired more than 10 companies. The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 29 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is Ampersand Capital Partners with 5 platform acquisitions.

Join Mergr and gain access to Hospira’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.4K Private Equity Firms
  • 119K M&A Transactions
  • 129K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.